Ubs Group Ag Armata Pharmaceuticals, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.46 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$518,1600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$246,2510.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$229,9990.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$173,3780.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $83.1M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...